Clinical Trial Update: Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of Ergoferon for treating acute respiratory viral infections in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Ergoferon

Snippet

Sponsor: Materia Medica Holding | Conditions: Acute Respiratory Viral Infections | Phase 4 | Status: COMPLETED | Results posted: 2020-04-27